David L Tait

Summary

Affiliation: Carolinas Medical Center
Country: USA

Publications

  1. ncbi A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study
    David L Tait
    Carolinas Medical Center, Blumenthal Cancer Center, Charlotte, NC 28203, USA
    Gynecol Oncol 121:118-21. 2011
  2. ncbi Correlation analysis of HOX, ErbB and IGFBP family gene expression in ovarian cancer
    Zahra Bahrani-Mostafavi
    Cannon Research Center, Molecular Biology Core Facility, Carolinas Medical Center, Charlotte, NC 28203, USA
    Cancer Invest 26:990-8. 2008

Collaborators

Detail Information

Publications2

  1. ncbi A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study
    David L Tait
    Carolinas Medical Center, Blumenthal Cancer Center, Charlotte, NC 28203, USA
    Gynecol Oncol 121:118-21. 2011
    ..The study aims to evaluate the anti-tumor activity and toxicity of gemcitabine in patients with persistent or recurrent endometrial carcinoma...
  2. ncbi Correlation analysis of HOX, ErbB and IGFBP family gene expression in ovarian cancer
    Zahra Bahrani-Mostafavi
    Cannon Research Center, Molecular Biology Core Facility, Carolinas Medical Center, Charlotte, NC 28203, USA
    Cancer Invest 26:990-8. 2008
    ..Our data indicates that the significantly modeled relationships between HOX, ErbB and IGFBP gene pairs could provide insight into the underlying biological mechanisms in ovarian cancer...